{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:28Z","timestamp":1793381068780,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10753-019-01012-2","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T08:03:02Z","timestamp":1555920182000},"page":"1491-1503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["FSTL1 Promotes Inflammatory Reaction and Cartilage Catabolism through Interplay with NF\u03baB Signaling Pathways in an In Vitro ONFH Model"],"prefix":"10.1007","volume":"42","author":[{"given":"Yuan","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"5","key":"1012_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5312\/wjo.v3.i5.49","volume":"3","author":"AP Kaushik","year":"2012","unstructured":"Kaushik, A.P., A. Das, and Q. Cui. 2012. Osteonecrosis of the femoral head: an update in year 2012. World Journal of Orthopedics 3 (5): 49\u201357. \n                    https:\/\/doi.org\/10.5312\/wjo.v3.i5.49\n                    \n                  .","journal-title":"World Journal of Orthopedics"},{"issue":"8","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5312\/wjo.v6.i8.590","volume":"6","author":"J Moya-Angeler","year":"2015","unstructured":"Moya-Angeler, J., A.L. Gianakos, J.C. Villa, A. Ni, and J.M. Lane. 2015. Current concepts on osteonecrosis of the femoral head. World Journal of Orthopedics 6 (8): 590\u2013601. \n                    https:\/\/doi.org\/10.5312\/wjo.v6.i8.590\n                    \n                  .","journal-title":"World Journal of Orthopedics"},{"issue":"19","key":"1012_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2106\/JBJS.O.00071","volume":"97","author":"MA Mont","year":"2015","unstructured":"Mont, M.A., J.J. Cherian, R.J. Sierra, L.C. Jones, and J.R. Lieberman. 2015. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. The Journal of Bone and Joint Surgery. American Volume 97 (19): 1604\u20131627. \n                    https:\/\/doi.org\/10.2106\/jbjs.o.00071\n                    \n                  .","journal-title":"The Journal of Bone and Joint Surgery. American Volume"},{"issue":"3","key":"1012_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3238\/arztebl.2016.0031","volume":"113","author":"D Arbab","year":"2016","unstructured":"Arbab, D., and D.P. Konig. 2016. Atraumatic femoral head necrosis in adults. Deutsches \u00c4rzteblatt International 113 (3): 31\u201338. \n                    https:\/\/doi.org\/10.3238\/arztebl.2016.0031\n                    \n                  .","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"4","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1155\/2012\/896986","volume":"33","author":"S Samara","year":"2012","unstructured":"Samara, S., P. Kollia, Z. Dailiana, C. Chassanidis, L. Papatheodorou, T. Koromila, and K.N. Malizos. 2012. Predictive role of cytokine gene polymorphisms for the development of femoral head osteonecrosis. Disease Markers 33 (4): 215\u2013221. \n                    https:\/\/doi.org\/10.3233\/dma-2012-0928\n                    \n                  .","journal-title":"Disease Markers"},{"issue":"2","key":"1012_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10753-017-0715-1","volume":"41","author":"B Chen","year":"2018","unstructured":"Chen, B., Y. Liu, and L. Cheng. 2018. IL-21 enhances the degradation of cartilage through the JAK-STAT signaling pathway during osteonecrosis of femoral head cartilage. Inflammation 41 (2): 595\u2013605. \n                    https:\/\/doi.org\/10.1007\/s10753-017-0715-1\n                    \n                  .","journal-title":"Inflammation"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"196702","DOI":"10.1155\/2015\/196702","volume":"2015","author":"JK Li","year":"2015","unstructured":"Li, J.K., L. Cheng, Y.P. Zhao, Y.J. Guo, Y. Liu, W. Zhang, S.S. Wang, Y.Q. Zhang, X. Pan, and L. Nie. 2015. ADAMTS-7 exhibits elevated expression in cartilage of osteonecrosis of femoral head and has a positive correlation with TNF-alpha and NF-kappa B P65. Mediators of Inflammation 2015: 196702. \n                    https:\/\/doi.org\/10.1155\/2015\/196702\n                    \n                  .","journal-title":"Mediators of Inflammation"},{"issue":"9","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/intimm\/10.9.1305","volume":"10","author":"M Tanaka","year":"1998","unstructured":"Tanaka, M., S. Ozaki, F. Osakada, K. Mori, M. Okubo, and K. Nakao. 1998. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. International Immunology 10 (9): 1305\u20131314.","journal-title":"International Immunology"},{"issue":"1","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/intimm\/dxg005","volume":"15","author":"M Tanaka","year":"2003","unstructured":"Tanaka, M., S. Ozaki, D. Kawabata, M. Kishimura, F. Osakada, M. Okubo, M. Murakami, K. Nakao, and T. Mimori. 2003. Potential preventive effects of follistatin-related protein\/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. International Immunology 15 (1): 71\u201377.","journal-title":"International Immunology"},{"issue":"1\u20133","key":"1012_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12026-014-8526-z","volume":"59","author":"Y Chaly","year":"2014","unstructured":"Chaly, Y., B. Hostager, S. Smith, and R. Hirsch. 2014. Follistatin-like protein 1 and its role in inflammation and inflammatory diseases. Immunologic Research 59 (1\u20133): 266\u2013272. \n                    https:\/\/doi.org\/10.1007\/s12026-014-8526-z\n                    \n                  .","journal-title":"Immunologic Research"},{"issue":"13","key":"1012_CR11","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00018-018-2805-0","volume":"75","author":"A Mattiotti","year":"2018","unstructured":"Mattiotti, A., S. Prakash, P. Barnett, and M.J.B. van den Hoff. 2018. Follistatin-like 1 in development and human diseases. Cellular and Molecular Life Sciences 75 (13): 2339\u20132354. \n                    https:\/\/doi.org\/10.1007\/s00018-018-2805-0\n                    \n                  .","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"1012_CR12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1096\/fj.201700265R","volume":"32","author":"R Qu","year":"2018","unstructured":"Qu, R., X. Chen, W. Wang, C. Qiu, M. Ban, L. Guo, K. Vasilev, J. Chen, W. Li, and Y. Zhao. 2018. Ghrelin protects against osteoarthritis through interplay with Akt and NF-kappaB signaling pathways. The FASEB Journal 32 (2): 1044\u20131058. \n                    https:\/\/doi.org\/10.1096\/fj.201700265R\n                    \n                  .","journal-title":"The FASEB Journal"},{"issue":"1","key":"1012_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4049\/jimmunol.182.1.234","volume":"182","author":"SD Clutter","year":"2009","unstructured":"Clutter, S.D., D.C. Wilson, A.D. Marinov, and R. Hirsch. 2009. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. Journal of Immunology 182 (1): 234\u2013239.","journal-title":"Journal of Immunology"},{"issue":"4","key":"1012_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/art.33422","volume":"64","author":"Y Chaly","year":"2012","unstructured":"Chaly, Y., A.D. Marinov, L. Oxburgh, D.S. Bushnell, and R. Hirsch. 2012. FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine\/chemokine expression. Arthritis and Rheumatism 64 (4): 1082\u20131088. \n                    https:\/\/doi.org\/10.1002\/art.33422\n                    \n                  .","journal-title":"Arthritis and Rheumatism"},{"key":"1012_CR15","doi-asserted-by":"publisher","first-page":"752519","DOI":"10.1155\/2013\/752519","volume":"2013","author":"N Fan","year":"2013","unstructured":"Fan, N., H. Sun, Y. Wang, Y. Wang, L. Zhang, Z. Xia, L. Peng, et al. 2013. Follistatin-like 1: a potential mediator of inflammation in obesity. Mediators Inflamm 2013: 752519. \n                    https:\/\/doi.org\/10.1155\/2013\/752519\n                    \n                  .","journal-title":"Mediators Inflamm"},{"issue":"8","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/icb.2017.26","volume":"95","author":"BT Campfield","year":"2017","unstructured":"Campfield, B.T., T. Eddens, M. Henkel, M. Majewski, W. Horne, Y. Chaly, S.L. Gaffen, R. Hirsch, and J.K. Kolls. 2017. Follistatin-like protein 1 modulates IL-17 signaling via IL-17RC regulation in stromal cells. Immunology and Cell Biology 95 (8): 656\u2013665. \n                    https:\/\/doi.org\/10.1038\/icb.2017.26\n                    \n                  .","journal-title":"Immunology and Cell Biology"},{"issue":"5","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/iep.12035","volume":"94","author":"S Okazaki","year":"2013","unstructured":"Okazaki, S., S. Nagoya, K. Tateda, R. Katada, K. Mizuo, S. Watanabe, T. Yamashita, and H. Matsumoto. 2013. Experimental rat model for alcohol-induced osteonecrosis of the femoral head. International Journal of Experimental Pathology 94 (5): 312\u2013319. \n                    https:\/\/doi.org\/10.1111\/iep.12035\n                    \n                  .","journal-title":"International Journal of Experimental Pathology"},{"issue":"1","key":"1012_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/labinvest.2014.134","volume":"95","author":"S Okazaki","year":"2015","unstructured":"Okazaki, S., S. Nagoya, H. Matsumoto, K. Mizuo, M. Sasaki, S. Watanabe, T. Yamashita, and H. Inoue. 2015. Development of non-traumatic osteonecrosis of the femoral head requires toll-like receptor 7 and 9 stimulations and is boosted by repression on nuclear factor kappa B in rats. Laboratory Investigation 95 (1): 92\u201399. \n                    https:\/\/doi.org\/10.1038\/labinvest.2014.134\n                    \n                  .","journal-title":"Laboratory Investigation"},{"issue":"1","key":"1012_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/scrt98","volume":"3","author":"L Rackwitz","year":"2012","unstructured":"Rackwitz, L., L. Eden, S. Reppenhagen, J.C. Reichert, F. Jakob, H. Walles, O. Pullig, R.S. Tuan, M. Rudert, and U. Noth. 2012. Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Research & Therapy 3 (1): 7. \n                    https:\/\/doi.org\/10.1186\/scrt98\n                    \n                  .","journal-title":"Stem Cell Research & Therapy"},{"issue":"11","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1365-2893.2006.00767.x","volume":"13","author":"CY Dai","year":"2006","unstructured":"Dai, C.Y., W.L. Chuang, L.P. Lee, S.C. Chen, N.J. Hou, Z.Y. Lin, M.Y. Hsieh, M.Y. Hsieh, L.Y. Wang, W.Y. Chang, and M.L. Yu. 2006. Associations of tumour necrosis factor alpha promoter polymorphisms at position \u2212308 and \u2212238 with clinical characteristics of chronic hepatitis C. Journal of Viral Hepatitis 13 (11): 770\u2013774. \n                    https:\/\/doi.org\/10.1111\/j.1365-2893.2006.00767.x\n                    \n                  .","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"1012_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0014-4827(03)00180-0","volume":"288","author":"A Liacini","year":"2003","unstructured":"Liacini, A., J. Sylvester, W.Q. Li, W. Huang, F. Dehnade, M. Ahmad, and M. Zafarullah. 2003. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Experimental Cell Research 288 (1): 208\u2013217.","journal-title":"Experimental Cell Research"},{"issue":"4","key":"1012_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1254\/jphs.FM0070288","volume":"106","author":"JT Woo","year":"2008","unstructured":"Woo, J.T., T. Yonezawa, B.Y. Cha, T. Teruya, and K. Nagai. 2008. Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival. Journal of Pharmacological Sciences 106 (4): 547\u2013554.","journal-title":"Journal of Pharmacological Sciences"},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bone.2018.08.011","volume":"116","author":"G Kuroyanagi","year":"2018","unstructured":"Kuroyanagi, G., N.S. Adapala, R. Yamaguchi, N. Kamiya, Z. Deng, O. Aruwajoye, M. Kutschke, E. Chen, C. Jo, Y. Ren, and H.K.W. Kim. 2018. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model. Bone 116: 221\u2013231. \n                    https:\/\/doi.org\/10.1016\/j.bone.2018.08.011\n                    \n                  .","journal-title":"Bone"},{"issue":"13","key":"1012_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2106\/JBJS.15.01209","volume":"98","author":"R Yamaguchi","year":"2016","unstructured":"Yamaguchi, R., N. Kamiya, N.S. Adapala, H. Drissi, and H.K. Kim. 2016. HIF-1-dependent IL-6 activation in articular chondrocytes initiating synovitis in femoral head ischemic osteonecrosis. The Journal of Bone and Joint Surgery. American Volume 98 (13): 1122\u20131131. \n                    https:\/\/doi.org\/10.2106\/jbjs.15.01209\n                    \n                  .","journal-title":"The Journal of Bone and Joint Surgery. American Volume"},{"issue":"6","key":"1012_CR25","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar3522","volume":"13","author":"Y Wang","year":"2011","unstructured":"Wang, Y., D. Li, N. Xu, W. Tao, R. Zhu, R. Sun, W. Fan, P. Zhang, T. Dong, and L. Yu. 2011. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis. Arthritis Research & Therapy 13 (6): R193. \n                    https:\/\/doi.org\/10.1186\/ar3522\n                    \n                  .","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"1012_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jcp.26580","volume":"234","author":"S Ni","year":"2018","unstructured":"Ni, S., C. Li, N. Xu, X. Liu, W. Wang, W. Chen, Y. Wang, and A.J. van Wijnen. 2018. Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK\/STAT3 and NF-kappaB pathways. Journal of Cellular Physiology 234 (1): 454\u2013463. \n                    https:\/\/doi.org\/10.1002\/jcp.26580\n                    \n                  .","journal-title":"Journal of Cellular Physiology"},{"issue":"26","key":"1012_CR27","doi-asserted-by":"publisher","first-page":"43023","DOI":"10.18632\/oncotarget.17400","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y., J. Wei, Y. Zhao, Y. Zhang, Y. Han, B. Chen, K. Cheng, J. Jia, L. Nie, and L. Cheng. 2017. Follistatin-like protein 1 promotes inflammatory reactions in nucleus pulposus cells by interacting with the MAPK and NFkappaB signaling pathways. Oncotarget 8 (26): 43023\u201343034. \n                    https:\/\/doi.org\/10.18632\/oncotarget.17400\n                    \n                  .","journal-title":"Oncotarget"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-01012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:19:58Z","timestamp":1587424798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-01012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-01012-2","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"22 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All the authors hereby state that they do not possess financial interests and they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}